公开(公告)号：US20170313764A1

公开(公告)日：2017-11-02

申请号：US15508570

申请日：2015-09-07

Applicant: AIMM THERAPEUTICS B.V.

Inventor： Tim BEAUMONT ,  Sabrina Julia Louisa MERAT ,  Cornelia Johanna SCHINKEL ,  Richard MOLENKAMP

IPC: C07K16/10

CPC classification number: C07K16/109 ,  C07K2317/21 ,  C07K2317/34 ,  C07K2317/76 ,  C07K2317/92

Abstract: The invention relates to isolated, synthetic or recombinant antibodies and functional parts thereof specific for hepatitis C virus (HCV). The invention further relates to the use of such antibodies for diagnosis, treatment and prevention of HCV infection.